Glukóza Viaflo Baxter Czech

Glukóza Viaflo Baxter Czech is an intravenous glucose solution marketed in the European Union. It contains glucose as the sole active ingredient and is supplied as a sterile liquid for infusion. The product is used to provide a rapid source of carbohydrate energy in clinical settings where oral intake is not possible or insufficient.

Glukóza Viaflo Baxter Czech is employed in various medical situations that require immediate carbohydrate supplementation. It is commonly used: - To treat hypoglycemia in patients unable to ingest food orally. - As an energy source during surgery or intensive care. - In parenteral nutrition regimens for patients with prolonged fasting. - To support patients with metabolic disorders requiring controlled glucose administration. - For diagnostic glucose tolerance testing when oral administration is contraindicated.

Side effects of intravenous glucose solutions are generally related to the infusion process and the metabolic impact of glucose.

Common: - Hyperglycemia (elevated blood glucose levels). - Local irritation or pain at the infusion site. - Nausea or vomiting. - Fluid overload in susceptible patients.

Serious: - Severe hyperglycemia leading to ketoacidosis. - Electrolyte imbalances, particularly hyponatremia. - Allergic reactions such as rash or anaphylaxis (rare). - Pulmonary edema in patients with compromised cardiac function.

When using Glukóza Viaflo Baxter Czech, several safety considerations should be observed: - Assess blood glucose levels before and during infusion to avoid hyperglycemia. - Adjust infusion rates in patients with renal or cardiac insufficiency to prevent fluid overload. - Monitor electrolytes, especially sodium and potassium, during prolonged administration. - Use caution in pregnant or lactating individuals; consult clinical guidelines. - Ensure aseptic technique to reduce the risk of infection at the infusion site. - Verify compatibility with other IV solutions to prevent precipitation.

Glucose solutions can interact with certain medications and clinical conditions.

Avoid: - Co-administration with insulin without appropriate dose adjustments, as it may cause severe hypoglycemia. - Use with drugs that contain high concentrations of sodium or potassium, which may exacerbate electrolyte disturbances.

Use with caution: - Concurrent use of corticosteroids, which can increase blood glucose levels. - Patients receiving diuretics, due to potential shifts in fluid and electrolyte balance. - Medications that affect renal function, such as ACE inhibitors or NSAIDs. - Situations involving rapid infusion of large volumes, which may affect cardiac output.